Comment on

• Evaluation of pretest clinical score (4 T's) for the diagnosis of heparin-induced thrombocytopenia in two clinical settings.

  Lo GK, Juhl D, Warkentin TE, Sigouin CS, Eichler P, Greinacher A. Lo GK, et al. J Thromb Haemost. 2006 Apr;4(4):759-65. doi: 10.1111/j.1538-7836.2006.01787.x. J Thromb Haemost. 2006. PMID: 16634744
• Quantitative interpretation of optical density measurements using PF4-dependent enzyme-immunoassays.

  Warkentin TE, Sheppard JI, Moore JC, Sigouin CS, Kelton JG. Warkentin TE, et al. J Thromb Haemost. 2008 Aug;6(8):1304-12. doi: 10.1111/j.1538-7836.2008.03025.x. Epub 2008 May 17. J Thromb Haemost. 2008. PMID: 18489711
• Fondaparinux treatment of acute heparin-induced thrombocytopenia confirmed by the serotonin-release assay: a 30-month, 16-patient case series.

  Warkentin TE, Pai M, Sheppard JI, Schulman S, Spyropoulos AC, Eikelboom JW. Warkentin TE, et al. J Thromb Haemost. 2011 Dec;9(12):2389-96. doi: 10.1111/j.1538-7836.2011.04487.x. J Thromb Haemost. 2011. PMID: 21883878